Lista de obras -

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view

artículo científico publicado en 2013

A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy

artículo científico publicado en 2014

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma

artículo científico publicado en 2011

BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer

artículo científico publicado en 2012

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

artículo científico publicado en 2012

Both BRAF V600E Mutation and Older Age (≥65 Years) are Associated with Recurrent Papillary Thyroid Cancer ⬇️

artículo científico publicado el 19 de mayo de 2011

Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”

scientific article published on 01 February 2010

Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies

scientific article published on 14 March 2012

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

artículo científico publicado en 2014

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

artículo científico publicado en 2011

Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer

artículo científico publicado en 2012

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology

artículo científico publicado en 2013

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.

artículo científico publicado en 2009

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma

artículo científico publicado en 2014

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers

artículo científico publicado en 2013

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted.

artículo científico publicado en 2015

Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancer

artículo científico publicado en 2014

Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma

artículo científico publicado en 2012

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

artículo científico publicado en 2014

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics

artículo científico publicado en 2014

Thyroid paragangliomas are locally aggressive.

artículo científico publicado en 2011

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.

artículo científico publicado en 2015

Lista de obras de

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view

A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy

A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma

BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Both BRAF V600E Mutation and Older Age (≥65 Years) are Associated with Recurrent Papillary Thyroid Cancer ⬇️

Contribution of molecular testing to thyroid fine-needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance”

Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology

Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted.

Surgeon volume and adequacy of thyroidectomy for differentiated thyroid cancer

Suspicious ultrasound characteristics predict BRAF V600E-positive papillary thyroid carcinoma

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics

Thyroid paragangliomas are locally aggressive.

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.